Prognostic factors and family history for survival of esophageal squamous cell carcinoma patients after surgery.

BACKGROUND Surgical resection is the most effective treatment for patients with isolated esophageal cancer, but the 5-year survival rate is still very poor in spite of recent advances in early diagnosis and extended lymphadenectomy. To identify the high-risk group and the factors affecting postoperative course, we analyzed the prognostic factors including the family history of esophageal cancer in survival after esophagectomy. METHODS A total of 1,553 patients with esophageal squamous cell carcinoma after surgery were the subject of the present study. Thirty-one percent of all these patients have family history of esophageal cancer. The prognostic factors analyzed in this study included age, sex, tumor size, tumor location, lymphadenopathy, histologic type, grade of differentiation, stage of cancer, adjuvant treatments, and family history of esophageal cancer. RESULTS The overall 3-year and 5-year postoperative survival rates were 43.7% and 26.2%, respectively, for all patients with esophagectomy. The five prognostic factors determined as significant by univariate p value were tumor size, lymphadenopathy, grade of differentiation, stage of cancer, and family history of esophageal cancer. Multivariate analysis showed that the independent prognostic factors were tumor size, grade of differentiation, stage of cancer, and family history of esophageal cancer. Our study also found that patients in groups with mid and upper segment esophageal squamous cell carcinoma, smaller tumor size, earlier stage of cancer, and poor differentiation of tumor cells had a significantly higher rate of positive family history than in the other groups, respectively. CONCLUSIONS Tumor size, grade of differentiation, lymphadenopathy, stage of cancer, and family history of esophageal cancer were identified as prognostic factors after esophagectomy. Family history of esophageal cancer is an important prognostic factor that surgeons should take into consideration when selecting a treatment method.

[1]  M. Suntharalingam,et al.  Preoperative versus postoperative chemoradiotherapy in the trimodality management of esophageal cancer. , 2009, Clinical advances in hematology & oncology : H&O.

[2]  N. Altorki,et al.  Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases. , 2009, The Annals of thoracic surgery.

[3]  N. Hu,et al.  Family history of cancer and risk for esophageal and gastric cancer in Shanxi, China , 2009, BMC Cancer.

[4]  K. Chow,et al.  Prognosis of esophageal squamous cell carcinoma: analysis of clinicopathological and biological factors , 1999, American Journal of Gastroenterology.

[5]  S. Natsugoe,et al.  Significant Host- and Tumor-Related Factors for Predicting Prognosis in Patients With Esophageal Carcinoma , 2003, Annals of surgery.

[6]  A. Meysamie,et al.  Prognostic factors in survival of colorectal cancer patients after surgery , 2009, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[7]  S. Singletary,et al.  Prognostic Factors in Node-Negative Breast Cancer: A Review of Studies With Sample Size More Than 200 and Follow-Up More Than 5 Years , 2002, Annals of surgery.

[8]  K. Hiroshima,et al.  Prediction of prognosis and surgical indications for pulmonary metastasectomy from colorectal cancer. , 2006, The Annals of thoracic surgery.

[9]  D. Wen,et al.  Early onset, multiple primary malignancies, and poor prognosis are indicative of an inherited predisposition to esophageal squamous cell carcinoma for the familial as opposed to the sporadic cases--an update on over 14-year survival. , 2009, European journal of medical genetics.

[10]  M. Tachibana,et al.  Esophageal cancer patients surviving 6 years after esophagectomy , 2002, Langenbeck’s Archives of Surgery.

[11]  H. Hsu,et al.  An audit of surgical outcomes of esophageal squamous cell carcinoma. , 2007, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[12]  R. Malekzadeh,et al.  Germline BRCA2 mutations and the risk of esophageal squamous cell carcinoma , 2007, Oncogene.

[13]  V. Rusch,et al.  The prognostic importance of the number of involved lymph nodes in esophageal cancer: implications for revisions of the American Joint Committee on Cancer staging system. , 2006, The Journal of thoracic and cardiovascular surgery.